A -year-old man is admitted to the hospital with newly diagnosed Burkitt lymphoma. He has a massive tumor burden and is scheduled to receive intensive induction chemotherapy. Baseline laboratory studies reveal a serum uric acid of mg/dL, potassium of mEq/L, phosphorus of mg/dL, and creatinine of mg/dL.
Arrange the following steps in the most appropriate chronological order for the prevention and stepwise management of tumor lysis syndrome in this patient.
- 1Initiate aggressive intravenous hydration and administer a hypouricemic agent.
- 2Commence the cytotoxic induction chemotherapy regimen.
- 3Perform serial laboratory monitoring of serum electrolytes, uric acid, and renal function.
- 4Administer targeted medical therapy (e.g., calcium gluconate, insulin) if severe electrolyte derangements occur.
- 5Initiate hemodialysis if the patient develops refractory acute kidney injury or intractable electrolyte abnormalities.
Answer
The correct chronological sequence is: (1) Initiate prophylaxis with hydration and a hypouricemic agent, (2) Commence chemotherapy, (3) Perform serial laboratory monitoring, (4) Administer targeted medical therapy for electrolyte derangements, and (5) Initiate hemodialysis if medical management fails.
The management of patients at high risk for tumor lysis syndrome follows a strict chronological algorithm to prevent severe morbidity from massive intracellular constituent release. The sequence mandates pre-medication (aggressive hydration and hypouricemic agents) to optimize renal clearance, followed by the inciting event (chemotherapy). Subsequent care relies on aggressive serial monitoring, escalating to targeted medical therapy for initial derangements, and reserving hemodialysis for refractory, life-threatening cases.
Step-by-Step Solution
Key Concept
Prevention and sequential management of Tumor Lysis Syndrome (TLS) in high-risk hematologic malignancies.